Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-02-03 | Graves’ Disease | ETA2023

Analysis of cost and treatment effects in the care given for graves disease - a swedish cost-utility analysis

Lindholm Lars , Sjolin Gabriel , Jonsson Annika , Wallin Goran , Filipsson Nystrom Helena

Background: Guidelines in healthcare shall be evidence-based, satisfy patients’ needs and improve patients’ outcomes. We aimed to estimate incremental costs after the introduction of a national guideline for Graves’ disease in Sweden adding the Graves’ Recurrent Events After Therapy (GREAT) score with genetic determinants to predict recurrence, a thyroid nurse, calcium-D-vitamin treatment preoperatively, and thyroid stimulating immunoglobulins.<p class=...